Category Specific RSS

Samantha Freidin

Qantas CEO’s egged on by Rex as feud gets personal?

I thought the ‘Other Costs & Expenses Excluding Fuel’ figure was a bit high in Rex’s (ASX: REX) half year…

4 years ago

This article is like The Magic School Bus

CF33-hNIS-antiPDL1. *moves mouse to x button to close tab* “But wait!” your writer screams from the page, “I promise it's…

4 years ago

Acrux’s generic cold sore cream accepted for review by FDA, set to disrupt Zovirax

With today’s insane cost of living, if there’s a cheaper option to something you best believe I’m picking it. I…

4 years ago

Aptar Pharma pulls the $7m trigger, recognising potential of Pharmaxis inhaler

Aptar Pharma has deemed now the perfect time to exercise their option to purchase an inventive piece of Pharmaxis’ (ASX:…

4 years ago

Getting things from A to B isn’t as simple as it seems, until Yojee gets involved

I recently bought a gorgeous coat from an American website. This thing has travelled the world, having been made in…

4 years ago

NASDAQ biotech stocks have taken a hit, but this little Aussie biotech is quietly confident

Clinical stage pharmaceutical company, Pharmaxis (ASX: PXS) has spent the quarter waiting and watching.  As clinical trials on their lead…

4 years ago